From February 24–26, 2026, the multi-city event series “Inside the FDA: Strategy & Guidance with Dr. Adam Saltman ”brought together leading experts and industry stakeholders across three locations in Germany.
In collaboration with Virtonomy GmbH and PAConsult GmbH, we welcomed more than 100 medical device professionals across Munich, Ochsenhausen (near Ulm) and Berlin. The strong participation clearly reflected the continued demand for practical, experience-based guidance on U.S. FDA strategy and evolving regulatory expectations.
Dr. Adam Saltman, Chief Medical Officer at NAMSA and former Medical Officer at the U.S. FDA, shared insights drawn from more than 12 years at the FDA combined with extensive industry experience. His sessions addressed increasing regulatory requirements, common pitfalls in FDA interactions and the anticipated direction of the agency. The candid reflections and real-world examples resonated strongly with participants across all three locations.
Each event concluded with an interactive discussion, allowing attendees to raise specific strategic and operational questions in an open and focused setting. The combination of expert insight and peer exchange made the series particularly valuable for companies preparing for or actively navigating U.S. regulatory pathways.
We are especially grateful for the opportunity to host the Berlin session at our offices and were genuinely pleased to welcome so many familiar and new faces in person. Creating a space for meaningful dialogue, thoughtful questions and honest exchange is something we value deeply. We hope you enjoyed the event as much as we did from the host’s perspective.
We would like to thank all partners and participants for contributing to such an insightful and solution-oriented dialogue across all three locations. Exchanges like these are increasingly important as our industry continues to navigate growing regulatory complexity and evolving expectations.
Published on: March 24, 2026
